TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 7 | -0 | 2 | 1 | 14 | 19 | 28 | 11 |
| S | %wins | 57 | 29 | 43 | 14 | 14 | 14 | 29 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/12 17:37 | 5/3/12 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Beier David W | CA | O | SVP,Glob | M.d | 3,074 | 55.89 | 33 | 55 | 36 | D | 29 | 23 | 29 | 1 | 5 | 5 | -1 | -1 | 2 | 2 | -1 | 19 | 25 | 54 | |
5/7/12 17:37 | 5/3/12 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Beier David W | CA | O | SVP,Glob | S.d | -3,889 | 70.72 | 33 | -55 | -61 | 36 | D | 29 | 23 | 29 | 1 | 5 | 5 | -1 | -1 | 2 | 2 | -1 | 19 | 25 | 54 |
2/7/12 20:32 | 2/7/12 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Beier David W | CA | O | SVP,Glob | M.d | 1,089 | 54.44 | 33 | 20 | 168 | 32 | D | 21 | 27 | 34 | 25 | 9 | 2 | 2 | -1 | -2 | -1 | -3 | 1 | 20 | 26 |
2/7/12 20:32 | 2/7/12 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Beier David W | CA | O | SVP,Glob | S.d | -1,378 | 68.88 | 33 | -20 | -39 | 32 | D | 21 | 27 | 34 | 25 | 9 | 2 | 2 | -1 | -2 | -1 | -3 | 1 | 20 | 26 |
1/31/12 20:41 | 1/27/12 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Beier David W | CA | O | SVP,Glob | M.d | 2,794 | 48.59 | 33 | 58 | 32 | D | 18 | 25 | 26 | 18 | 17 | 6 | -1 | -1 | 3 | 2 | 1 | 5 | 24 | 28 | |
1/31/12 20:41 | 1/27/12 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Beier David W | CA | O | SVP,Glob | S.d | -3,937 | 68.47 | 33 | -58 | -64 | 32 | D | 18 | 25 | 26 | 18 | 17 | 6 | -1 | -1 | 3 | 2 | 1 | 5 | 24 | 28 |
8/15/11 18:50 | 8/15/11 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Beier David W | CA | O | SVP Glob | S | -773 | 51.56 | 33 | -15 | -32 | 32 | D | -18 | -9 | -7 | -17 | -14 | -9 | -6 | -1 | 0 | 1 | 7 | 13 | 35 | 65 |
6/5/09 13:00 | 6/3/09 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Beier David W | CA | O | SVP Glob | S | -347 | 50.43 | 33 | -7 | -12 | 53 | D | -11 | 15 | -7 | 8 | 9 | 6 | 1 | 2 | 0 | -2 | 2 | 16 | 13 | 7 |
10/24/08 19:13 | 10/23/08 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Beier David W | CA | O | SVP Glob | S | -154 | 52.88 | 33 | -3 | -6 | 50 | D | -24 | -4 | 31 | 3 | -12 | -6 | 8 | 4 | -5 | 6 | -5 | -5 | -13 | -2 |
5/28/08 18:51 | 5/27/08 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Beier David W | CA | O | SVP Glob | S | -387 | 43.01 | 33 | -9 | -15 | 53 | D | -37 | -21 | -20 | -10 | -1 | 0 | 2 | 2 | 1 | 3 | 9 | 49 | 28 | 16 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |